Biomarker World Congress 2012
May 21 - 23, 2012 | Philadelphia, PA

The leading annual meeting dedicated to biomarker research and implementation



Conference Programs

Track 1: Biomarkers in Drug Development

  • Biomarkers for drug safety assessment
  • Biomarkers in clinical trials
  • Translational biomarkers
  • Personalized medicine

Track 2: Molecular Diagnostics

  • Biomarker assay development
  • Laboratory-developed tests
  • Next-generation "Omics" diagnostics

Track 3: Executive Summit: Drug-Diagnostic Co-Development

  • Drug-diagnostic co-development case studies
  • Partnering strategies
  • Regulatory requirements for companion diagnostics

Plenary Keynotes

Felix FruehFelix W. Frueh, Ph.D., President, Medco Research Institute, Medco Health Solutions, Inc.

Nicholas Dracopoli Nicholas C. Dracopoli, Ph.D., Vice President, Biomarkers, Centocor R&D, Johnson & Johnson

Geert Kolvenbag Geert Kolvenbag, M.D., Ph.D., Vice President,
Global Product, AstraZeneca



Pre-Conference Events:

Short Course: Fit-for-Purpose Biomarker Assay Development and Validation

New Company Showcase and Partnering Forum:
Next-Generation Biomarkers and Diagnostics